On 02 November, Avnet, Inc. (NYSE:AVT) shares moved up 0.26% and was closed at $45.55. AVT EPS growth in last 5 year was 9.00%. Avnet, Inc. (NYSE:AVT) year to date (YTD) performance is 7.06%.
Avnet, Inc. (NYSE:AVT) announced results for the first quarter fiscal year 2016 ended October 3, 2015.Excluding the estimated sales for the extra week in the first quarter of fiscal 2016 of approximately $525 million, year-over-year organic sales in constant currency would have increased 0.7% and organic sales would have declined 5.8%.Year-over-year sales growth rate excluding the impact of changes in foreign currency exchange rates.
Vicon Industries, Inc. (NYSEMKT:VII) ended the last trading day at $1.70. Company weekly volatility is calculated as 1.46% and price to cash ratio as 6.81. Vicon Industries, Inc. (NYSEMKT:VII) showed a weekly performance of 0.62%.
On October 27, 2015, Vicon Industries, Inc. (NYSEMKT:VII) announced that the Compensation Committee of the Board of Directors approved a performance based bonus of $75,000 for Eric S. Fullerton, Chief Executive Officer, contingent upon the achievement of certain operating results, as defined, for the fiscal year ended September 30, 2015.
On 02 November, Arrow Financial Corporation (NASDAQ:AROW) shares advanced 0.87% and was closed at $27.84. AROW EPS growth in last 5 year was 0.90%. Arrow Financial Corporation (NASDAQ:AROW) year to date (YTD) performance is 4.15%.
The Board of Directors of Arrow Financial Corporation (NasdaqGS®: AROW) on October 28, 2015, declared a quarterly cash dividend of $0.25 per share payable December 15, 2015, to shareholders of recordDecember 3, 2015. This represents an increase of 2% over the cash dividend paid in the fourth quarter of 2014, as a result of theSeptember 28, 2015, 2% stock dividend. It also represents the 22nd consecutive year that cash dividends paid to shareholders have increased.
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) shares advanced 2.89% in last trading session and ended the day at $11.05. VNDA Gross Margin is 84.70% and its has a return on assets of 30.60%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) quarterly performance is -11.95%.
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced it release results for the third quarter of 2015 on Tuesday, November 3, 2015, after the market closes. The Company will host a conference call at 4:30 PM ET on Tuesday, November 3, 2015, during which Vanda management will discuss the third quarter 2015 financial results and other corporate activities.
Merck & Co. Inc. (NYSE:MRK) caters to the Healthcare space. It has a net profit margin of 24.50% and weekly performance is 4.16%. On the last day of trading company shares ended up at $55.11. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 6.34%.
Merck & Co. Inc. (NYSE:MRK) third-quarter profit more than doubled as heavy cost-cutting more than offset lower sales and the negative effects of a strong dollar. The maker of diabetes pill Januvia beat Wall Street’s profit expectations and edged up its 2015 profit forecast, despite lower sales for vaccines and drugs for high cholesterol, HIV and immune disorders. Third-quarter net income totaled $1.83 billion, or 64 cents per share, up from $895 million, or 31 cents per share. Excluding acquisition, divestiture, restructuring and other one-time items totaling $894 million after taxes, adjusted net income was $2.72 billion, or 96 cents per share. Analysts expected 91 cents per share.
Leave a Reply